Company Overview
Company Type: Public Company
Website: www.hologic.com
Number of Employees: 6,944
Ticker: HOLX (NasdaqGS)
Year Founded: 1985


Business Description
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Financial Information (Currency: CAD, in mm) 
Total Revenue
5,523.5
Market Capitalization
23,247.5
TEV/Total Revenue
4.2x
EBITDA
1,757.7
Total Enterprise Value
23,317.5
TEV/EBITDA
13.0x
EBIT
1,272.9
Cash & ST Invst.
3,814.7
P/Diluted EPS Before Extra
35.7x
Net Income
662.1
Total Debt
3,884.8
Price/Tang BV
18.0x
Capital Expenditure
(176.9)
Total Assets
12,772.2
Total Debt/EBITDA
2.2x
Currency in CAD in mm, LTM as of Jul-01-2023 TEV and Market Cap are calculated using a close price as of Oct-05-2023


Estimates & Guidance Snapshot (Current Fiscal Year End: Sep-30-2023 | Currency: CAD)
Periodic Estimates
Current FQ
Guidance Current FQ
Current FY
Guidance Current FY
NTM
EPS Normalized
1.16
1.09 - 1.19
5.35
5.29 - 5.39
5.18
Revenue (mm)
1,285.86
1,244.68 - 1,299.39
5,503.30
5,464.28 - 5,518.99
5,444.43
EBITDA (mm)
399.88
-
1,793.00
-
1,753.68

Forward Multiples (Current FY)

Price/Earnings
17.75x
TEV/REV
4.24x
TEV/EBITDA
13.00x
PEG
6.88x
P/BV
3.25x

Non-Periodic Estimates

Recommendation
Outperform (2.37)
Target Price
118.56
Potential Upside
24.92%
LT Growth (%)
2.58%


Key Professionals
Name
Title
MacMillan, Stephen P.
Chairman, CEO & President
Oberton, Karleen M.
Chief Financial Officer
Malenchini, Paul 
Chief Information Officer
Simon, Ryan M.
Vice President of Investor Relations
Griffin, John M.
General Counsel
Hellmann, Elisabeth A.
Senior Vice President of Global Human Resources & Corporate Communications
Anderson, Erik 
Division President of Breast & Skeletal Health Solutions
Berthelot, Monica Aguirre
VP & Chief of Staff
Christensen, Scott 
Senior Vice President of Global Supply Chain, Quality & Regulatory
Mitchell, Essex 
Division President of GYN Surgical Solutions
Schneiders, Jennifer 
President of Diagnostics Solutions
Verstreken, Jan 
Group President of International

Key Board Members
Name
Title
MacMillan, Stephen P.
Chairman, CEO & President
Crawford, Sally Wellinghoff
Lead Independent Director
Dockendorff, Charles J.
Independent Director
Garrett, Scott T.
Independent Director
Hantson, Ludwig N.
Independent Director
Mohtashami, Nanaz 
Director
Nawana, Namal 
Independent Director
Stamoulis, Christiana 
Independent Director
Stewart, Stacey D.
Independent Director
Wendell, Amy M.
Independent Director


Primary Industry Classification
Health Care Equipment


Primary Office Location
250 Campus Drive | Marlborough, MA | 01752 | United States
Phone: 508 263 2900   

Current and Pending Investors
Elo Mutual Pension Insurance Company, Icahn Capital LP

Prior Investors
Ascent Venture Partners, LLC, Bellevue Asset Management AG, Capital Southwest Corporation (NasdaqGS:CSWC), Claflin Capital Management, Inc., Massachusetts Capital Resource Company, Sageview Capital LP, Saints Capital Services, LLC

Investment Arms
Cytyc Development Company, LLC (Prior), Hologic Inc., Asset Management Arm

Stock Quote and Chart (Currency: CAD)
Last  (Delayed)
 95.56
Market Cap (mm)
23,247.5
Open
 94.87
Shares Out. (mm)
244.9
Previous Close
 94.91
Float %
98.7%
Change on Day
0.65
Shares Sold Short (mm)
5.5
Change % on Day
0.7%
Dividend Yield %
-
Day High/Low
 96.07/ 94.18
Diluted EPS Excl. Extra Items
2.66
52 wk High/Low
 120.20/ 81.77
P/Diluted EPS Before Extra
35.96x
Volume (mm)
1.17
Avg 3M Dly Vlm (mm)
1.78
Beta 5Y
1.02


 
Delayed Quote** | Last Updated on Oct-06-2023 03:58 PM (GMT-5)
NasdaqGS:HOLX - Common Stock


Index Membership
S&P 500;S&P 500 Health Care (Sector);S&P Composite 1500;S&P 500 Growth;S&P Global 1200;S&P 500 Health Care Equipment (Sub Ind);S&P 500 Health Care Equipment & Services (Industry Group);S&P 500 Health Care Equipment & Supplies (Industry);S&P 500 Equal Weighted;S&P Healthcare Equipment Select Industry Index;S&P 900 Pure Growth;S&P 900 Growth;S&P TMI Index;S&P Global 1200 Health Care Index;S&P 900;S&P 500 Pure Growth;S&P Composite 1500 Health Care (Sector);S&P Composite 1500 Health Care Equipment & Services (Industry Group);S&P Composite 1500 Health Care Equipment & Supplies (Industry);S&P Composite 1500 Health Care Equipment (Sub Ind);S&P Composite 1500 Growth;S&P Composite 1500 Pure Growth;S&P 500 EQUAL WEIGHTED Health Care (Sector);S&P 500 Ex-Financials, Real Estate, Utilities and Transportation Index;S&P 500 Dividend Index;S&P Americas LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Americas BMI Growth Index;S&P Americas BMI Index;S&P Americas BMI Health Care (Sector) Index;S&P Americas LargeMidCap Health Care (Sector) Index;S&P Americas BMI Health Care Equipment & Services (Industry Group) Index;S&P Americas LargeMidCap Index;S&P Americas LargeMidCap Growth Index;S&P Americas Over USD5 Billion Index;S&P Developed Ex-Australia BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Asia-Pacific BMI Growth Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Europe BMI Growth Index;S&P Developed Ex-Europe LargeMidCap Index;S&P Developed Ex-Europe LargeMidCap Growth Index;S&P Developed BMI Index;S&P Developed Ex-Asia-Pacific BMI Growth Index;S&P Developed Ex-Asia-Pacific BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Asia-Pacific LargeMidCap Growth Index;S&P Developed Ex-Australia BMI Index;S&P Developed Ex-Australia LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Eurozone BMI Growth Index;S&P Developed BMI Growth Index;S&P Developed Ex-Asia-Pacific BMI Index;S&P Developed Ex-Australia LargeMidCap Index;S&P Developed Ex-Europe BMI Growth Health Care (Sector) Index;S&P Developed Ex-Canada BMI Index;S&P Developed Ex-Canada BMI Health Care (Sector) Index;S&P Developed Ex-Canada LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Switzerland BMI Index;S&P Developed Ex-Switzerland LargeMidCap Health Care (Sector) Index;S&P Developed Ex-U.K. LargeMidCap Health Care (Sector) Index;S&P Developed Ex-U.K. LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Europe LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Eurozone BMI Index;S&P Developed Ex-Eurozone LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Japan BMI Index;S&P Developed Ex-Japan BMI Growth Health Care (Sector) Index;S&P Developed Ex-Japan BMI Health Care (Sector) Index;S&P Developed Ex-Japan BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Asia-Pacific LargeMidCap Index;S&P Developed Ex-Australia LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Japan LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Switzerland BMI Health Care (Sector) Index;S&P Developed Ex-Eurozone LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Australia BMI Growth Index;S&P Developed Ex-Australia BMI Growth Health Care (Sector) Index;S&P Developed Ex-Australia BMI Health Care (Sector) Index;S&P Developed Ex-Australia LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Canada BMI Growth Health Care (Sector) Index;S&P Developed Ex-Switzerland BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Switzerland LargeMidCap Index;S&P Developed Ex-Switzerland LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-U.K. BMI Growth Health Care (Sector) Index;S&P Developed Ex-U.K. BMI Health Care (Sector) Index;S&P Developed Ex-Europe LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Eurozone BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Eurozone Over USD5 Billion Index;S&P Developed Ex-Switzerland LargeMidCap Growth Index;S&P Developed Ex-Canada BMI Growth Index;S&P Developed Ex-Europe BMI Index;S&P Developed Ex-Europe LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-U.K. BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-U.K. LargeMidCap Index;S&P Developed Ex-U.K. Over USD5 Billion Index;S&P Developed Ex-U.K. BMI Growth Index;S&P Developed Ex-U.K. LargeMidCap Growth Index;S&P Developed Ex-U.K. LargeMidCap Growth Health Care (Sector) Index;S&P Developed BMI Health Care (Sector) Index;S&P Developed BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Asia-Pacific LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific Over USD5 Billion Index;S&P Developed Ex-Europe Over USD5 Billion Index;S&P Developed Ex-Eurozone BMI Growth Health Care (Sector) Index;S&P Developed Ex-Japan LargeMidCap Index;S&P Developed Ex-Australia Over USD5 Billion Index;S&P Developed Ex-Canada LargeMidCap Index;S&P Developed Ex-Canada Over USD5 Billion Index;S&P Developed Ex-Europe BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Over USD5 Billion Index;S&P Global Ex-Pan Asia BMI Health Care (Sector) Index;S&P Developed Ex-Eurozone LargeMidCap Index;S&P Developed Ex-Japan LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Switzerland BMI Growth Index;S&P Developed Ex-Switzerland BMI Growth Health Care (Sector) Index;S&P Developed Ex-Switzerland LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed LargeMidCap Index;S&P Developed LargeMidCap Growth Index;S&P Developed Ex-Switzerland Over USD5 Billion Index;S&P Developed BMI Growth Health Care (Sector) Index;S&P Developed Ex-Canada LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Europe BMI Health Care (Sector) Index;S&P Developed Ex-Eurozone BMI Health Care (Sector) Index;S&P Developed Ex-Eurozone LargeMidCap Growth Index;S&P Developed Ex-Japan LargeMidCap Growth Index;S&P Developed Ex-Japan LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Japan Over USD5 Billion Index;S&P Global Ex-Japan LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Global Ex-Japan Over USD5 Billion Index;S&P Global Ex-Pan Asia BMI Health Care Equipment & Services (Industry Group) Index;S&P Global Ex-Pan Asia LargeMidCap Growth Index;S&P Developed Ex-U.K. BMI Index;S&P Global BMI Index;S&P Global BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Global Ex-Japan BMI Health Care (Sector) Index;S&P Global Ex-Japan BMI Health Care Equipment & Services (Industry Group) Index;S&P Global Ex-Japan LargeMidCap Index;S&P Global Ex-Pan Asia Over USD5 Billion Index;S&P North America BMI Health Care Equipment & Services (Industry Group) Index;S&P North America LargeMidCap Growth Index;S&P North America Over USD5 Billion Index;S&P Global Ex-Pan Asia LargeMidCap Health Care (Sector) Index;S&P Global Ex-Pan Asia LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Global LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Global Over USD5 Billion Index;S&P North America BMI Index;S&P North America LargeMidCap Index;S&P North America LargeMidCap Growth Health Care (Sector) Index;S&P Global Ex-Japan LargeMidCap Health Care (Sector) Index;S&P United States BMI Index;S&P Global LargeMidCap Health Care (Sector) Index;S&P Global BMI Growth Index;S&P United States BMI Growth Health Care (Sector) Index;S&P United States BMI Health Care (Sector) Index;S&P United States LargeMidCap Growth Index;S&P United States LargeMidCap Growth Health Care (Sector) Index;S&P United States LargeMidCap Health Care (Sector) Index;S&P United States Over USD5 Billion Index;S&P Global Ex-Japan BMI Growth Index;S&P Global Ex-Japan LargeMidCap Growth Index;S&P Global Ex-Pan Asia BMI Index;S&P Global Ex-Pan Asia BMI Growth Index;S&P Global Ex-Pan Asia LargeMidCap Index;S&P Global LargeMidCap Index;S&P United States BMI Growth Index;S&P North America BMI Growth Index;S&P North America BMI Growth Health Care (Sector) Index;S&P North America BMI Health Care (Sector) Index;S&P North America LargeMidCap Health Care (Sector) Index;S&P United States LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P United States BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Asia-Pacific BMI Health Care (Sector) Index;S&P Developed Ex-Australia LargeMidCap Growth Index;S&P Developed Ex-Canada BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Canada LargeMidCap Growth Index;S&P Developed Ex-Canada LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Eurozone LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Japan BMI Growth Index;S&P Developed LargeMidCap Growth Health Care (Sector) Index;S&P Developed LargeMidCap Health Care (Sector) Index;S&P Global BMI Health Care (Sector) Index;S&P Global Ex-Japan BMI Index;S&P Global LargeMidCap Growth Index;S&P North America LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P United States LargeMidCap Index;S&P North America BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Eurozone BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Canada BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Japan BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Europe BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Asia Pacific BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P United States BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Australia BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Switzerland BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-UK BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P TMI Health Care;S&P Developed Ex-Israel BMI Growth Index;S&P Developed Ex-Israel BMI Growth Health Care (Sector) Index;S&P Developed Ex-Israel BMI Index;S&P Developed Ex-Israel BMI Health Care (Sector) Index;S&P Developed Ex-Israel BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Israel LargeMidCap Growth Index;S&P Developed Ex-Israel LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Israel LargeMidCap Index;S&P Developed Ex-Israel LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Israel LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Israel Over USD5 Billion Index;S&P Global 1200 - Health Care Equipment & Services (Industry Group);S&P Global 1200 Health Care Equipment & Supplies (Industry);S&P Global 1200 Health Care Equipment (Sub Industry);S&P Global Ex-Australia BMI Index;S&P Global Ex-Europe BMI Index;S&P Global Ex-United Kingdom BMI Index;S&P Developed Ex-Continental Europe BMI Index;S&P Developed Ex-Japan, Ex-South Korea BMI Index;S&P Developed Ex. Japan LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Global Ex-Australia LargeMidCap;S&P Developed Ex-Japan & South Korea LargeMidCap;S&P Developed Ex-Europe LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.K. LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Canada LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Israel LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Switzerland LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Asia-Pacific LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Australia LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Israel BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Eurozone LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P United States LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P North America LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Global Ex-Australia & New Zealand LargeMidCap;S&P Global Ex-China A BMI;S&P Global Ex-China A LargeMidCap;S&P Developed Ex-Korea BMI;S&P Global Ex-Japan & China A LargeMidCap;S&P Developed Ex-Korea LargeMidCap;S&P Developed BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Asia Pacific BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Europe BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Japan BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Australia BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Eurozone BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Switzerland BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Japan LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P United States BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Asia Pacific LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Canada BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-UK LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P North America BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-UK BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Korea BMI Growth;S&P Developed Ex-Korea LargeMidCap Growth;S&P Global 1200 Ex-Canada;S&P Developed Ex-Korea LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Korea LargeMidCap Health Care Equipment & Services (Industry Group)


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Current and Pending Subsidiaries / Investments
Company Name
Business Description
Geography
Primary Industry
LTM Total Rev.($mm)
LFQ Total Assets ($mm)
LFQ Total Debt ($mm)
Bolder Surgical, LLC
Bolder Surgical Holdings, Inc. is a micro-laparoscopic medical device company that designs, develops, and manufactures right-sized surgical devices allowing access to confined and often delicate structures. Its products include JustRight Surgical Vessel Sealing System that provides precision instruments for general surgery where access to surgical sites with conventionally sized technology has been limited; CoolSeal Vessel Sealing platform; JustRight Generator, which delivers less than 25 watts of controlled energy; JustRight Sealer, a multi-function instrument for general surgery where access to surgical sites with conventionally-sized technology has been limited; and JustRight 5mm Stapler for general and pediatric surgery. The company also offers miniature surgical instruments for use in pediatric surgery and other delicate procedures. It serves healthcare providers in the United States. Bolder Surgical Holdings, Inc. was formerly known as Innovative Pediatric Devices, LLC and changed its name to Bolder Surgical Holdings, Inc. in April 2011. Bolder Surgical Holdings, Inc. was incorporated in 2010 and is based in Louisville, Colorado. As of November 29, 2021, Bolder Surgical, LLC operates as a subsidiary of Hologic, Inc.

United States and Canada
Health Care Supplies
5.00
-
-
Mobidiag Oy
Mobidiag Oy, doing business as Mobidiag Ltd., develops and provides molecular diagnostics for infectious diseases and antibiotic resistances in Finland and internationally. The company offers PCR-based tests for acute care conditions, such as gastrointestinal and respiratory infections, antimicrobial resistance management, healthcare associated infections, and Sepsis. Its products include Novodiag, an automated platform that enables immediate detection of infectious diseases directly from a single use cartridge; and Amplidiag, a family of diagnostic tests for mid to high-volume screening of infectious diseases. The company was founded in 2000 and is headquartered in Espoo, Finland with additional offices in France, United Kingdom, and Sweden. As of June 17, 2021, Mobidiag Oy operates as a subsidiary of Hologic, Inc.

Europe
Biotechnology
31.00
-
-
Diagenode S.A.
Diagenode S.A. develops and manufactures instruments and reagents systems for life science research and molecular diagnostics markets in Belgium and internationally. It offers pico sonication devices for shearing applications; sonication devices that provide DNA shearing for next-generation-sequencing; other sonication devices that process multiple samples in sealed tubes of 0.5 ml to 50 ml capacity; pico accessories; and devices and accessories for the fragmentation applications. The company also provides automated systems, semi-automation products, 3D cell culture plates, 3D micro pattern cell culture plates, and histone cell lines; kits that include chromatin function, DNA methylation, DNA and RNA purification, exosomes, library preparation, and protein extraction products; epigenetic reagents, including antibodies; and reagents that includes, proteins, beads and accessories, fixation reagents, primer pairs, inhibitors, enzymes, nucleotides, and plasmids. Its products are used in epigenetics DNA methylation, sequencing, epigenetics chromatin analysis, and protein analysis applications. It offers its products through a network of distributors. Diagenode S.A. was incorporated in 2003 and is based in Seraing, Belgium with additional offices in Concon, Chile; Denville, New Jersey; and Toyama, Japan. As of March 1, 2021, Diagenode S.A. operates as a subsidiary of Hologic, Inc.

Europe
Life Sciences Tools and Services
35.00
-
-
Certain Assets of NXC Imaging
As of September 28, 2020, Certain Assets of NXC Imaging was acquired by Hologic, Inc.. 

United States and Canada
-
-
-
-
BioTheranostics, Inc.
BioTheranostics, Inc. develops molecular-based diagnostic and predictive tests that provide physicians with actionable information to guide them in cancer treatment. The company offers the Breast Cancer Index, which helps oncologists make decisions about extended endocrine therapy for oestrogen receptor-positive breast cancer patients; the CancerTYPE ID test, which provides actionable genomic information for the diagnosis and treatment of metastatic cancer; and the bioT3 metastatic cancer solution, which combines accurate molecular diagnosis with comprehensive biomarker information that enables enhanced treatment for metastatic cancer patients. BioTheranostics, Inc. was formerly known as AviaraDx, Inc. and changed its name to BioTheranostics, Inc. in September 2008. The company was incorporated in 2007 and is based in San Diego, California. BioTheranostics, Inc. operates as a subsidiary of Hologic, Inc.

United States and Canada
Health Care Services
33.00
-
-
SOMATEX Medical Technologies GmbH
SOMATEX Medical Technologies GmbH engages in developing, manufacturing, and distributing minimal invasive disposable instruments for Vertebroplasty, biopsy, tumour ablation, tumor diagnostic and therapy, antenatal diagnostics, and antenatal medicine. It offers instruments in the areas of biopsy, bone marrow biopsy, breast care, MRI compatible products, assisted reproduction, AR-micropipettes, antenatal diagnostics, neonatal diagnostics, spine/vertebroplasty, drainage, radiation protection, lung interventions, and others. The company also provides marking wires, localization sets, puncture needles, and catheters used in ultrasound, mammography, magnetic resonance imaging (MRI), and CT. SOMATEX Medical Technologies GmbH was founded in 1992 and is based in Teltow, Germany. As of December 30, 2020, SOMATEX Medical Technologies GmbH operates as a subsidiary of Hologic, Inc.

Europe
Health Care Equipment
13.00
-
-
Acessa Health Inc.
Acessa Health Inc. manufactures radiofrequency ablation system Acessa System, for the treatment of symptomatic uterine fibroids. The company utilizes the technology to treat each fibroid by applying energy through a small needle array. It provides patients suffering from uterine fibroids a minimally invasive laparoscopic outpatient procedure. Acessa Health Inc. is headquartered in Austin, Texas. As of August 23, 2020, Acessa Health Inc. operates as a subsidiary of Hologic, Inc.

United States and Canada
Health Care Equipment
10.00
-
-


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
May-2-2023
-
Shelf Registration
Target
Hologic, Inc. (NasdaqGS:HOLX)


832.87
Nov-15-2022
-
Shelf Registration
Target
Hologic, Inc. (NasdaqGS:HOLX)


-
Sep-23-2022
-
Buyback
Target
Hologic, Inc. (NasdaqGS:HOLX)


1,000.00
Oct-14-2021
Nov-29-2021
Merger/Acquisition
Buyer
Bolder Surgical, LLC
Hologic, Inc. (NasdaqGS:HOLX)
Crescendo Capital Partners,River Cities Capital Fund Management,Providence Ventures, LLC,Westwood Management Corp.
159.20
Apr-08-2021
Jun-17-2021
Merger/Acquisition
Buyer
Mobidiag Oy
Hologic, Inc. (NasdaqGS:HOLX)
Autobio Diagnostics Co., Ltd. (SHSE:603658)
794.10
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
Sep-26-2023
Company Conference Presentations
Hologic, Inc. Presents at Outsourcing In Clinical Trials Southern California 2023, Sep-26-2023
Sep-26-2023
Company Conference Presentations
Hologic, Inc. Presents at Generis American Medical Device (AMD) Summit, Sep-26-2023
Sep-22-2023
Executive/Board Changes - Other
Nanaz Mohtashami Elected to Hologic, Inc.'S Board of Directors
Sep-21-2023
Client Announcements
Hologic Inc. and Bayer Announce International Partnership to Deliver Comprehensive Contrast- Enhanced Mammography Package to Breast Imaging Facilities
Sep-12-2023
Company Conference Presentations
Hologic, Inc. Presents at SERVICE COUNCIL SYMPOSIUM 2023 Smarter Services Executive Symposium, Sep-12-2023 04:45 PM

Competitors
Abbott Diagnostics Inc., Abbott Laboratories (NYSE:ABT), Abbott Molecular Inc., Accelerate Diagnostics, Inc. (NasdaqCM:AXDX), Acelity L.P. Inc., Agendia N.V., Agendia, Inc., Agiliti Health, Inc., Alcon Inc. (SWX:ALC), Amicon Corporation (Acquired), Applied BioCode Corporation (TWSE:6598), Applied Medical Inc., Apria Healthcare, Inc., Apria, Inc., aprimeo diagnostics GmbH & Co. KG, Aramark Corporation (Acquired), Argon Medical Devices, Inc., Arjo Inc., Ascom USA Inc., Avanos Medical, Inc. (NYSE:AVNS), Avatar Enterprises, Inc., Barton Medical Corporation, Bausch Health Companies Inc. (NYSE:BHC), Becton, Dickinson and Company (NYSE:BDX), BG Industries, Inc., Biocept, Inc. (NasdaqCM:BIOC), BioFire Diagnostics, LLC, bioMérieux S.A. (ENXTPA:BIM), Biomérieux S.A., ESOP, BioReference Health, LLC, BioTheranostics, Inc., Canon Inc. (TSE:7751), Care Logistics LLC, CareFusion Corporation, Caremed Supply, Inc., Cepheid, Inc., Cerner Corporation, Chembio Diagnostics, Inc., Chemed Corporation (NYSE:CHE), Clarient Diagnostic Services, Inc., Co-Diagnostics, Inc. (NasdaqCM:CODX), CONMED Corporation (NYSE:CNMD), Cook Medical Incorporated, CooperSurgical, Inc., Corona Diagnostics, LLC, Corona Medical SAS, Curetis N.V., Danaher Corporation (NYSE:DHR), DEKRA Testing & Inspection GmbH (Acquired), Densitas Inc., DENTSPLY SIRONA Inc. (NasdaqGS:XRAY), Devicor Medical Products, Inc., Diasorin Molecular LLC, DiaSorin S.p.A. (BIT:DIA), Dukane Communications Systems (Acquired), Eclipsys Patient Flow Solutions, LLC (Acquired), Edwards Lifesciences Corporation (NYSE:EW), Elekta AB (publ) (OM:EKTA B), Exact Sciences Corporation (NasdaqCM:EXAS), Exagen Inc. (NasdaqGM:XGN), Fitzsimmons Surgical Supply, Inc., Freedom Medical Inc., Fresenius Medical Care AG & Co. KGaA (XTRA:FME), Fuji Corporation (TSE:6134), FUJIFILM Holdings Corporation (TSE:4901), GE Healthcare Limited, General Electric Company (NYSE:GE), GenMark Diagnostics, Inc., Getinge AB (publ) (OM:GETI B), GF Health Products, Inc. (Out of Business), Grifols, S.A. (BME:GRF), GSK plc (LSE:GSK), Guardant Health, Inc. (NasdaqGS:GH), Guided Therapeutics, Inc. (OTCPK:GTHP), Gynesonics, Inc., Handicare AB, Hill-Rom Holdings, Inc., Hospira Inc., Human Care HC AB, Huntleigh Healthcare L.L.C. (Acquired), Huntleigh Technology Limited, Hyperfine, Inc. (NasdaqGM:HYPR), I.M.S. bv, iCAD, Inc. (NasdaqCM:ICAD), IDEXX Laboratories, Inc. (NasdaqGS:IDXX), Imaging3, Inc. (Acquired), Industrias H. Pardo SL, InMode Ltd. (NasdaqGS:INMD), Intego Software, LLC, Integra LifeSciences Holdings Corporation (NasdaqGS:IART), Intuitive Surgical, Inc. (NasdaqGS:ISRG), Invacare Florida Corporation, Joerns Healthcare, LLC, Joh. Stiegelmeyer GmbH & Co. KG, Koninklijke Philips N.V. (ENXTAM:PHIA), Laboratory Corporation of America Holdings (NYSE:LH), Leica Biosystems Nussloch Gmbh, LINAK A/S, Linet France SAS, Luminex Corporation, Lunit Inc. (KOSDAQ:A328130), Lutronic, Inc., Malvestio Spa, MAQUET GmbH, MedaSTAT USA, LLC. (Acquired), Medical Specialties Distributors, LLC, Medline Industries, Inc., Merit Medical Systems, Inc. (NasdaqGS:MMSI), Merivaara Corporation, Merz Pharma GmbH & Co. KGaA, Meso Scale Diagnostics, LLC, Meso Scale Discovery Inc., MetaStat, Inc. (OTCPK:MTST), Mettler-Toledo International Inc. (NYSE:MTD), Midtown Investments, LLC, Minerva Surgical, Inc. (NasdaqCM:UTRS), Mizuho OSI, Inc., Mobidiag Oy, Modular Services Company, Molift Group AS, Myriad Genetics, Inc. (NasdaqGS:MYGN), Myriad International GmbH, NanoString Technologies, Inc. (NasdaqGM:NSTG), Nemschoff, Inc., NeoGenomics, Inc. (NasdaqCM:NEO), Novartis AG (SWX:NOVN), Olympus Corporation (TSE:7733), OpGen, Inc. (NasdaqCM:OPGN), OPKO Health, Inc. (NasdaqGS:OPK), OrthoScan, Inc., Oy Medix Biochemica Ab, Pacific Edge Limited (NZSE:PEB), Paramount Bed Holdings Co., Ltd. (TSE:7817), Parascript, LLC, Pediatrix Medical Group, Inc. (NYSE:MD), Pegasus Airwave, Inc., Philips Medical Systems International B.V., Phillips Corporation, Planmed Oy, Qiagen Corporation, Qiagen N.V. (NYSE:QGEN), Quest Diagnostic Incorporated, Quest Diagnostics Incorporated (NYSE:DGX), Quest Diagnostics Infectious Disease, Inc., QuidelOrtho Corporation (NasdaqGS:QDEL), Qvella Corporation, Radianse, Inc. (Acquired), Randox Laboratories Ltd., Rauland-Borg Corporation, Reckitt Benckiser Group plc (LSE:RKT), RecoverCare, LLC (Acquired), ResMed Inc. (NYSE:RMD), Response Genetics, Inc (OTCPK:RGDX.Q), Revvity, Inc. (NYSE:RVTY), Robert Bosch GmbH, Roche Diagnostics GmbH, Roche Holding AG (SWX:ROG), Roche Molecular Systems Inc., Sciton, Inc., Screenpoint Medical B.V., Seegene, Inc. (KOSDAQ:A096530), SenTech Medical Systems, Inc., Shimadzu Corporation (TSE:7701), Siemens Corporation, Siemens Healthineers, Inc., Siemens Hearing Instruments Ltd, Siemens Limited (NSEI:SIEMENS), Siemens Medical Solutions USA, Inc., SimplexGrinnell LP, Sirona Dental Systems Inc., Sisram Medical Ltd (SEHK:1696), Sividon Diagnostics GmbH, Sizewise Rentals, LLC, Smith & Nephew plc (LSE:SN.), Span-America Medical Systems, Inc., Steelcase Inc. (NYSE:SCS), Sten Barr Medical, Inc., STERIS plc (NYSE:STE), Sunrise Medical, Inc., Syneron Medical Ltd., T2 Biosystems, Inc. (NasdaqCM:TTOO), Teleflex Incorporated (NYSE:TFX), TeleTracking Technologies, Inc., Tempur-Pedic Medical, Inc., Terumo Corporation (TSE:4543), The Cooper Companies, Inc. (NasdaqGS:COO), Therapixel SA, Thermo Fisher Scientific Inc. (NYSE:TMO), Tollos, Inc., Toshiba Corporation (TSE:6502), Tridien Medical, Inc., University Genomics, Inc., V. Guldmann A/S, Varex Imaging Corporation (NasdaqGS:VREX), VasoHealthcare, Veracyte Sd, Inc., Veracyte, Inc. (NasdaqGM:VCYT), Vieve Ltd, Viveve Medical, Inc. (OTCPK:VIVE), Volpara Solutions Inc., VuCOMP, Inc. (Acquired), Wallac Oy, Waverley Glen Systems Limited, Wellell Inc. (TWSE:4106), West Pharmaceutical Services, Inc. (NYSE:WST), West-Com Nurse Call Systems, Inc., Ziehm Imaging GmbH, Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

M&A Advisors
Avance Attorneys Ltd., Brown Rudnick LLP, Brown Rudnick LLP, London, Deutsche Bank Securities Inc., Ernst & Young LLP, Gibson, Dunn & Crutcher LLP, Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Jeantet & Associés, Jefferies LLC, Jones Day, Latham & Watkins LLP, Morgan Stanley & Co. LLC, Needham & Company, LLC, Perella Weinberg Partners (NasdaqGS:PWP), Raymond James & Associates, Inc., Richards, Layton & Finger, P.A., Skadden, Arps, Slate, Meagher & Flom LLP, Stibbe B.V. Cvba, Taylor Wessing LLP, The Goldman Sachs Group, Inc. (NYSE:GS), Wachtell, Lipton, Rosen & Katz LLP, Weil, Gotshal & Manges LLP


Advisors
Most Recent Auditor
Ernst & Young LLP
M&A Advisors
Avance Attorneys Ltd., Brown Rudnick LLP, Brown Rudnick LLP, London, Deutsche Bank Securities Inc., Ernst & Young LLP, Gibson, Dunn & Crutcher LLP, Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Jeantet & Associés, Jefferies LLC, Jones Day, Latham & Watkins LLP, Morgan Stanley & Co. LLC, Needham & Company, LLC, Perella Weinberg Partners (NasdaqGS:PWP), Raymond James & Associates, Inc., Richards, Layton & Finger, P.A., Skadden, Arps, Slate, Meagher & Flom LLP, Stibbe B.V. Cvba, Taylor Wessing LLP, The Goldman Sachs Group, Inc. (NYSE:GS), Wachtell, Lipton, Rosen & Katz LLP, Weil, Gotshal & Manges LLP
Public Offering Advisors
Brown Rudnick LLP, Brown Rudnick LLP, London, Brownstein Hyatt Farber Schreck, LLP, Ernst & Young LLP, Whyte Hirschboeck Dudek S.C.
Bankruptcy Advisors
Jaffe Raitt Heuer & Weiss, P.C.


Most Recent Auditor
Ernst & Young LLP


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
GlobalData

06:08 AM
HOLX
Hologic Inc (HOLX.NASD) - Medical Equipment - Deals and Alliances Profile
Reports
124
S&P Global Compustat

Oct 05, 2023 03:18 AM
HOLX
Hologic Inc 2023_10_05
Reports
18
GlobalData

Oct 05, 2023 03:08 AM
HOLX
Hologic Inc (HOLX.NASD) - Financial and Strategic SWOT Analysis Review
Reports
196
Trucost Plc
S&P Trucost Research Team
Oct 04, 2023 08:14 AM
HOLX
Trucost Environmental Briefing: Hologic Inc
Reports
13
Trucost Plc
S&P Trucost Research Team
Oct 04, 2023 08:13 AM
HOLX
Trucost Environmental Skyline: Hologic Inc
Reports
1
Baptista Research
Majumdar, Ishan
Oct 02, 2023 11:49 PM
HOLX
Hologic, Inc.: Decoding the Reasons Behind the Double-Digit Molecular Growth! - Major Drivers, Financial Forecasts, DCF & Comparable Valuation, ESG & Other Risks (09/23)
Ratings Change*
49
ValuEngine, Inc.

Oct 02, 2023 04:37 AM
HOLX
ValuEngine Rating and Forecast Report for HOLX
Reports
11
The Economy Matters

Oct 02, 2023 03:07 AM
HOLX
The Economy Matters
Reports
8
CFRA Equity Research
Meyer, Paige
Sep 30, 2023 04:49 PM
HOLX
Hologic, Inc.
Reports
9
New Constructs, LLC

Sep 29, 2023 08:19 PM
HOLX
HOLX: Forensic Stock Earnings & Valuation
Reports
6


Ownership Summary

            Top Holders 
Holders by Type
Holder

Common Stock Equivalent Held

% of Total Shares Outstanding

Market Value (CAD in mm)

Position Date


The Vanguard Group, Inc.

28,500,515

11.64

2,708.2

Jun-30-2023


T. Rowe Price Group, Inc.

24,189,256

9.88

2,298.5

Jun-30-2023


BlackRock, Inc.

23,849,548

9.74

2,266.2

Jun-30-2023


State Street Global Advisors, Inc.

11,542,769

4.71

1,096.8

Jun-30-2023


Wellington Management Group LLP

9,604,686

3.92

912.7

Jun-30-2023


Geode Capital Management, LLC

5,391,310

2.20

512.3

Jun-30-2023


Macquarie Investment Management Business Trust

5,325,421

2.17

506.0

Jun-30-2023


Victory Capital Management Inc.

4,444,719

1.81

422.3

Jun-30-2023


Parnassus Investments, LLC

3,786,427

1.55

359.8

Jun-30-2023


Columbia Management Investment Advisers, LLC

3,522,143

1.44

334.7

Jun-30-2023



 



Top Buyers
Buyers
Common Stock Equivalent Held
Change
Congress Asset Management Company, LLP
1,191,518
1,191,518
MacMillan, Stephen P.
2,314,304
1,176,108
Millennium Management LLC
1,040,665
913,647
Wellington Management Group LLP
9,604,686
619,929
Citadel Advisors LLC
1,236,277
561,576

Top Sellers
Sellers
Common Stock Equivalent Held
Change
Pacer Advisors, Inc.
21,535
(1,346,239)
Arrowstreet Capital, Limited Partnership
2,809,457
(1,237,148)
Perpetual Limited
0
(969,803)
Victory Capital Management Inc.
4,444,719
(741,990)
PGIM, Inc.
233,170
(721,847)


S&P Global Ratings Credit Ratings
Debt Type (Rating Type)
Current Rating
Rating Date
Current CreditWatch / Outlook
Current CreditWatch / Outlook Date
Issuer Credit Rating (Local Currency LT)
BBB-
Nov-09-2021
Stable
11/9/2021 4:30:06 PM
Issuer Credit Rating (Foreign Currency LT)
BBB-
Nov-09-2021
Stable
11/9/2021 4:30:06 PM


News Headlines
No News is currently available for the selected sources.


Company Coverage
This company is not on any Coverage List.

Products
2D and 3D Digital Mammography System, 3Dimensions Gantry, Acessa ProVu System, Affirm Prone Breast Biopsy Table, Affirm Upright Attachment System, Aptima BV Assays, Aptima CMV Quant Assay (Future), Aptima Combo 2, Aptima CV/TV Assays, Aptima Flu Multiplex, Aptima HIV-1 Quant, Aptima HPV Test, Aptima HSV 1 & 2, Aptima Mycoplasma Genitalium Assay, Aptima SARS-CoV-2 Assay, Aptima SARS-CoV-2/Flu Assay, Aptima Trichomonas Vaginalis, Aptima Virology Assays, ATEC and Brevera Disposables, ATEC Vacuum-assisted Breast Biopsy Devices, Bacterial Vaginosis and Candida Vaginitis Assays, BodyLogic Scan, Breast Biopsy Site Markers, Breast Conserving Surgery Products, Brevera Breast Biopsy Devices, C-View System, Celero Biopsy Device, Cellulaze Laser Device, Cervista HPV Tests, Clarity HD, Computer-Aided Detection Software, Connectivity Solutions, Contura Multi-Lumen Balloon Brachytherapy System, Cynergy, Definity Cervical Dilator, Discovery X-ray Bone Densitometers, Distribution of Alexa System, Distribution of Extremity MRI systems, Dual Kinetic Assay Technology, Elite, Eviva Breast Biopsy Devices, Fluent Fluid Management System, Fluoroscan Insight FD, Full 2D Field Digital Mammography System, Genius AI Detection, Genius Digital Diagnostics System, HBV Quant, HCV Quant Dx, HEV Assays, Horizon DXA, Horizon X-ray Bone Densitometers, Hybridization Protection Assay, Hysteroscopic Fluid Management System, Icon Aesthetic System, ImageChecker CAD, Installation and Repair Services, Intelligent 2D, Invader Chemistry Platform, Localization and Specimen Radiology Solutions, Maintenance and Support Services, MammoPad Breast Cushion, MammoSite ML Radiation Therapy System, MammoSite Radiation Therapy System, Medical Aesthetics Systems, MedLite, Minimally Invasive Breast Biopsy Guidance Systems and Devices, Molecular Diagnostic Assays, MonaLisa Touch, MRI Visualization Product, MultiCare Platinum and Affirm Prone, Multiplex Real-time PCR Assays, MyoSure Hysteroscopic Tissue Removal System, NAAT for M. Genitalium, NAT Assays, Nitronox, NovaSure ADVANCED Device, NovaSure CLASSIC Endometrial Ablation System, NovaSure Disposable Device, NovaSure RF Controller, NovaSure V5 Device, NovaSure V5 Global Endometrial Ablation Device, Novodiag RESP-4 Molecular Diagnostic Test, Omni scope, Panther Fusion BKV Quant Assay, Panther Fusion Bordetella Assay, Panther Fusion EBV Quant Assay, Panther Fusion MRSA Assay, Panther Fusion Paraflu Assay, Panther Fusion SARS-CoV-2 Assay, Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay, Panther Fusion System, Panther Instrument System, Panther Trax, Petite Submental Mask, PicoSure, Procleix Blood Screening Assays, Progensa PCA3 Assay, Quantra Software, R2 DigitalNow HD Software, Rapid Fetal Fibronectin Test, Reading Workstation Solutions, Remanufactured Selenia System, RevLite, Sahara Clinical Bone Sonometers, Sales of SmartCool Treatment Cooling System, Screen-film Mammography Systems, SculpSure, SecurViewDX Workstation, SecurViewRT Workstation, Selenia Base Configuration, Selenia Dimensions and 3Dimensions Systems, Selenia Value, Semi-Automated Direct Tube Sampling Instruments, Sentinelle Endo Coil Array, Sertera Biopsy Device, SmartCure, SmartLipo, Spare Parts, Stapler, StereoLoc II Upright Attachment, SuperSonic MACH 40, Synchro REPLA:Y, Target Capture/Nucleic Acid Extraction Technology, Technical Support Services, TempSure Envi, TempSure System, TempSure Vitalia Handpiece and Probes, ThinPrep Cytology System, ThinPrep Imaging System, ThinPrep Integrated Imager, ThinPrep Pap Test, ThinPrep PreservCyt Solution, ThinPrep Processor, ThinPrep System, Tigris System, Tomcat Instrument, Towerfree Hysteroscopy System, Training and Ongoing Services, Transcription-Mediated Amplification Technology, Trident Specimen Radiography System, Ultraportable Wireless Solutions, Ultrasound Carts, Unifi Workspace, Vectus Diode Laser, Vessel Sealing Devices, Viral Load Assays, Viral Load Tests, WNV Assay


Upcoming Events
Date/Time
Type
Oct-30-2023
Estimated Earnings Release Date (S&P Global Derived)
Nov-09-2023
Earnings Release Date
Nov-09-2023 4:30 PM (EST)
Earnings Calls
* Future Events are subject to change.


Recent Major Filings

Key Filings
Filed On
Period Date
Company Name
Source
Form Type
Size
Sep-22-2023
Sep-20-2023
Hologic, Inc. (NasdaqGS:HOLX)
SEC
8-K (5.02, 9.01)
176 KB
Aug-01-2023
Jul-01-2023
Hologic, Inc. (NasdaqGS:HOLX)
SEC
10-Q
10 MB
Jul-31-2023
Jul-31-2023
Hologic, Inc. (NasdaqGS:HOLX)
SEC
8-K (2.02, 9.01)
1 MB
May-02-2023
-
Hologic, Inc. (NasdaqGS:HOLX)
SEC
S-8
98 KB
May-02-2023
Apr-01-2023
Hologic, Inc. (NasdaqGS:HOLX)
SEC
10-Q
10 MB
May-01-2023
May-01-2023
Hologic, Inc. (NasdaqGS:HOLX)
SEC
8-K (2.02, 9.01)
1 MB
Apr-19-2023
Apr-17-2023
Hologic, Inc. (NasdaqGS:HOLX)
SEC
8-K (5.02, 8.01, 9.01)
142 KB
Mar-10-2023
Mar-09-2023
Hologic, Inc. (NasdaqGS:HOLX)
SEC
8-K (5.02, 5.07, 9.01)
424 KB
Feb-01-2023
Feb-01-2023
Hologic, Inc. (NasdaqGS:HOLX)
SEC
8-K (2.02, 9.01)
796 KB
Feb-01-2023
Dec-31-2022
Hologic, Inc. (NasdaqGS:HOLX)
SEC
10-Q
8 MB


Insider Trades
Holder Name
Trade Date Range
Security Type
Transacted Shares
Transaction Value Range (CAD)
Transaction Type
% Change
Source
Mohtashami, Nanaz  (Director)
Sep-20-2023
restricted stock units
745
0
Other Acquisition
New
Form 4
MacMillan, Stephen P. (Chairman, CEO & President)
Aug-30-2023
Common Stock
(1,064,954)
0
Other Disposition
(31.51)
Form 4
Verstreken, Jan  (Group President of International)
Jun-30-2023
Common Stock
(322)
(35,661)
Sale to Issuer
(0.41)
Form 4
Garrett, Scott T. (Independent Director)
Jun-15-2023
Common Stock
(10,000)
(1,090,449)
Open Market Disposition
(16.02)
Form 4
Mitchell, Essex  (Division President of GYN Surgical Solutions)
May-05-2023
Common Stock
(2,390)
(273,714)
Open Market Disposition
(24.89)
Form 4
Excluding Automatic Transactions
Key Board Members Details
Name
Title
Phone
Fax
Email
MacMillan, Stephen P.
Chairman, CEO & President
508 263 2900
-

Crawford, Sally Wellinghoff
Lead Independent Director
508 263 2900
-

Dockendorff, Charles J.
Independent Director
508 263 2900
-

Garrett, Scott T.
Independent Director
508 263 2900
-

Hantson, Ludwig N.
Independent Director
508 263 2900
-

Mohtashami, Nanaz 
Director
508 263 2900
-

Nawana, Namal 
Independent Director
508 263 2900
-

Stamoulis, Christiana 
Independent Director
(617) 945-5576
-

Stewart, Stacey D.
Independent Director
508 263 2900
-
sstewart@marchofdimes.com
Wendell, Amy M.
Independent Director
508 263 2900
-

* denotes that the relationship is proprietary

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
MacMillan, Stephen P.
Chairman, CEO & President
508 263 2900
-

Oberton, Karleen M.
Chief Financial Officer
508 263 2900
-

Malenchini, Paul 
Chief Information Officer
508 263 2900
-

Simon, Ryan M.
Vice President of Investor Relations
508 263 2900
-

Griffin, John M.
General Counsel
508 263 2900
-
john.griffin@hologic.com
Hellmann, Elisabeth A.
Senior Vice President of Global Human Resources & Corporate Communications
508 263 2900
-

Anderson, Erik 
Division President of Breast & Skeletal Health Solutions
508 263 2900
-

Berthelot, Monica Aguirre
VP & Chief of Staff
508 263 2900
-

Christensen, Scott 
Senior Vice President of Global Supply Chain, Quality & Regulatory
508 263 2900
-

Mitchell, Essex 
Division President of GYN Surgical Solutions
508 263 2900
-

Schneiders, Jennifer 
President of Diagnostics Solutions
508 263 2900
-

Verstreken, Jan 
Group President of International
508 263 2900
-

* denotes that the relationship is proprietary

Historical Equity Pricing Data supplied by Interactive Data Pricing and Reference Data LLC 
S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 

**Intraday Quotes are delayed by at least 20 minutes.
